Cargando…

Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)(2)D(3)

BACKGROUND: The 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) together with parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) regulates calcium (Ca(2+)) and phosphate (Pi) homeostasis, 1,25(OH)(2)D(3) synthesis is mediated by hydroxylases of the cytochrome P450 (Cyp) family. Vitamin D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kägi, Larissa, Bettoni, Carla, Pastor-Arroyo, Eva M., Schnitzbauer, Udo, Hernando, Nati, Wagner, Carsten A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5957386/ https://www.ncbi.nlm.nih.gov/pubmed/29771914 http://dx.doi.org/10.1371/journal.pone.0195427

Ejemplares similares

The human pathogenic 91del7 mutation in SLC34A1 has no effect in mineral homeostasis in mice
por: Bieri, Cornelia, et al.
Publicado: (2022)

The intestinal phosphate transporter NaPi-IIb (Slc34a2) is required to protect bone during dietary phosphate restriction
por: Knöpfel, Thomas, et al.
Publicado: (2017)

Renal Dnase1 expression is regulated by FGF23 but loss of Dnase1 does not alter renal phosphate handling
por: Egli-Spichtig, Daniela, et al.
Publicado: (2021)

Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)(2)D, but No Difference in Ratio of 25(OH)D/24,25(OH)(2)D and FGF23 Concentrations
por: Vlot, Mariska C, et al.
Publicado: (2019)

Elevated FGF23 and disordered renal mineral handling with reduced bone mineralization in chronically erythropoietin over-expressing transgenic mice
por: Daryadel, Arezoo, et al.
Publicado: (2019)

Hyperphosphatemia with elevated serum PTH and FGF23, reduced 1,25(OH)(2)D and normal FGF7 concentrations characterize patients with CKD
por: Kritmetapak, Kittrawee, et al.
Publicado: (2021)

Evaluation of Serum Level of FGF23 and 1,25(OH)(2)D(3) in Primary Hyperparathyroidism Patients Before and After Parathyroidectomy
por: Hassani, Solmaz, et al.
Publicado: (2020)

Phosphate and FGF-23
por: Jüppner, Harald
Publicado: (2011)

Association among plasma 1,25(OH)(2)D, ratio of 1,25(OH)(2)D to 25(OH)D, and prostate cancer aggressiveness
por: Ramakrishnan, Swathi, et al.
Publicado: (2019)

Vitamin D, 1,25-Dihydroxyvitamin D, FGF23, and Graft Function after Renal Transplantation
por: Mehrotra, Sonia, et al.
Publicado: (2019)

1,25-Dihydroxyvitamin D(3) regulates furin-mediated FGF23 cleavage
por: Xie, Han, et al.
Publicado: (2023)

Does the composition of urinary extracellular vesicles reflect the abundance of renal Na(+)/phosphate transporters?
por: Radvanyi, Zsuzsi, et al.
Publicado: (2022)

Serum FGF23 levels may not be associated with serum phosphate and 1,25-dihydroxyvitamin D levels in patients with Fanconi syndrome–induced hypophosphatemia
por: Goto, Shunsuke, et al.
Publicado: (2016)

Expression of phosphate and calcium transporters and their regulators in parotid glands of mice
por: Moser, Seraina O., et al.
Publicado: (2022)

Intact FGF23 predicts serum phosphate improvement after combined nicotinamide and phosphate binder treatment in hemodialysis patients
por: Egli-Spichtig, Daniela, et al.
Publicado: (2023)

Vitamin D and 1,25(OH)(2)D Regulation of T cells
por: Cantorna, Margherita T., et al.
Publicado: (2015)

Extrarenal Nephroblastoma
por: Teerthanath, S
Publicado: (2011)

Extrarenal nephroblastoma
por: Apoznański, Wojciech, et al.
Publicado: (2015)

Differential and Overlapping Effects of 20,23(OH)(2)D3 and 1,25(OH)(2)D3 on Gene Expression in Human Epidermal Keratinocytes: Identification of AhR as an Alternative Receptor for 20,23(OH)(2)D3
por: Slominski, Andrzej T., et al.
Publicado: (2018)

Assessment of 24,25(OH)2D levels does not support FGF23-mediated catabolism of vitamin D metabolites
por: Dai, Bing, et al.
Publicado: (2012)

FGF23 and Vitamin D Metabolism
por: Latic, Nejla, et al.
Publicado: (2021)

25(OH)D and 1,25(OH)D vitamin D fails to predict sepsis and mortality in a prospective cohort study
por: Ratzinger, Franz, et al.
Publicado: (2017)

PSAT173 Weekly Supplementation with Vitamin D3 reduces 1,25(OH)2 vitamin D3 Measured by Mass Spectrometry, and increases Fibroblast-like growth factor 23 (FGF23) in Individuals with and without Primary Hyperparathyroidism (PHPT)
por: Sidana, Shivani, et al.
Publicado: (2022)

Central role of the proximal tubular αKlotho/FGF receptor complex in FGF23-regulated phosphate and vitamin D metabolism
por: Takeshita, Ai, et al.
Publicado: (2018)

FGF23, alpha-Klotho and vitamin D mediated calcium-phosphate metabolism in haemodialysis patients
por: Pasaoglu, Ozge Tugce, et al.
Publicado: (2021)

FGF23 and Phosphate–Cardiovascular Toxins in CKD
por: Vogt, Isabel, et al.
Publicado: (2019)

Constitutive depletion of Slc34a2/NaPi-IIb in rats causes perinatal mortality
por: Pastor-Arroyo, Eva Maria, et al.
Publicado: (2021)

Interactions between FGF23 and vitamin D
por: Razzaque, Mohammed S
Publicado: (2022)

Fibroblast Growth Factor 23 (FGF23) and Disorders of Phosphate Metabolism
por: Saito, Tasuku, et al.
Publicado: (2009)

Molecular interactions of FGF23 and PTH in phosphate regulation
por: Lanske, Beate, et al.
Publicado: (2014)

Extrarenal retroperitoneal angiomyolipoma with oncocytoma
por: Ali, Amir Mahmud, et al.
Publicado: (2018)

Extrarenal Teratoid Wilms Tumor
por: Unny, Ashitha K., et al.
Publicado: (2022)

Single-cell RNA sequencing identifies Fgf23-expressing osteocytes in response to 1,25-dihydroxyvitamin D(3) treatment
por: Hanai, Ayako, et al.
Publicado: (2023)

Antidepressants differentially related to 1,25-(OH)(2) vitamin D(3) and 25-(OH) vitamin D(3) in late-life depression
por: Oude Voshaar, R C, et al.
Publicado: (2014)

Does Sevelamer Hydrochloride (Renagel) Influence 25(Oh)D3 and 1,25(Oh)2D3 Level in Haemodialysis Patients?
por: Strózecki, Pawel, et al.
Publicado: (2005)

25(OH)D(3) and 1.25(OH)(2)D(3) inhibits TNF-α expression in human monocyte derived macrophages
por: Rafique, Aisha, et al.
Publicado: (2019)

MON-LB74 The Problem of Measuring 1,25(OH)2 Vitamin D in Patients With High Levels of 25(OH) Vitamin D
por: Vieira, Jose Gilberto, et al.
Publicado: (2020)

Circulatory 25(OH)D and 1,25(OH)(2)D as differential biomarkers between multiple system atrophy and Parkinson's disease patients
por: Ogura, Hiromu, et al.
Publicado: (2021)

25(OH)D-but not 1,25(OH)(2)D–Is an independent risk factor predicting graft loss in stable kidney transplant recipients
por: Zeng, Shufei, et al.
Publicado: (2023)

Vitamin D (1,25(OH)(2)D3) induces α-1-antitrypsin synthesis by CD4(+) T cells, which is required for 1,25(OH)(2)D3-driven IL-10
por: Dimeloe, Sarah, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_odkrfk0achl8kgu06kv7ktl8e4